Woodline Partners’s Editas Medicine EDIT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-846,399	Closed	-$1.86M	–	932
2025 Q2	$1.86M	Buy	+846,399	New	+$1.38M	0.01%	731
2025 Q1	–	Sell	-838,419	Closed	-$1.06M	–	932
2024 Q4	$1.06M	Sell	838,419 -62,002	-7%	-$158K	0.01%	748
2024 Q3	$3.07M	Sell	900,421 -70,070	-7%	-$305K	0.03%	438
2024 Q2	$4.53M	Buy	970,491 +75,491	+8%	+$426K	0.04%	349
2024 Q1	$6.64M	Sell	895,000 -401	-0%	-$3.33K	0.06%	333
2023 Q4	$9.07M	Sell	895,401 -2,364,309	-73%	-$20.8M	0.1%	241
2023 Q3	$25.4M	Buy	3,259,710 +510,405	+19%	+$4.38M	0.3%	99
2023 Q2	$22.6M	Buy	2,749,305 +102,685	+4%	+$895K	0.27%	110
2023 Q1	$19.2M	Buy	2,646,620 +567,872	+27%	+$5.05M	0.27%	108
2022 Q4	$18.4M	Buy	+2,078,748	New	+$22.8M	0.25%	123
2022 Q3	–	Sell	-1,016,891	Closed	-$12M	–	774
2022 Q2	$12M	Buy	1,016,891 +994,020	+4,346%	+$13.3M	0.2%	152
2022 Q1	$435K	Buy	+22,871	New	+$425K	0.01%	522